95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
26.00%
Positive revenue growth while RGLD is negative. John Neff might see a notable competitive edge here.
-1.07%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-1.07%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-1.07%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
8.72%
Positive net income growth while RGLD is negative. John Neff might see a big relative performance advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
8.98%
Slight or no buybacks while RGLD is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
8.94%
Slight or no buyback while RGLD is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
22.62%
Positive OCF growth while RGLD is negative. John Neff would see this as a clear operational advantage vs. the competitor.
113.34%
Positive FCF growth while RGLD is negative. John Neff would see a strong competitive edge in net cash generation.
252.80%
10Y revenue/share CAGR 1.25-1.5x RGLD's 217.78%. Bruce Berkowitz would investigate brand strength or geographical expansion fueling growth.
46.85%
5Y revenue/share CAGR 1.25-1.5x RGLD's 37.20%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
-28.54%
Negative 3Y CAGR while RGLD stands at 9.80%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
388.16%
10Y OCF/share CAGR in line with RGLD's 383.78%. Walter Schloss would see both as similarly efficient over the decade.
38.42%
5Y OCF/share CAGR at 50-75% of RGLD's 58.34%. Martin Whitman would question if the firm lags in monetizing revenue effectively.
-44.68%
Negative 3Y OCF/share CAGR while RGLD stands at 0.30%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
230.32%
Net income/share CAGR above 1.5x RGLD's 32.52% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
-14.41%
Negative 5Y net income/share CAGR while RGLD is 6.96%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-66.75%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
1009.18%
10Y equity/share CAGR 1.25-1.5x RGLD's 728.41%. Bruce Berkowitz would see if strong ROE or conservative payout policy fosters faster book value growth.
105.03%
5Y equity/share CAGR above 1.5x RGLD's 27.12%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
37.47%
3Y equity/share CAGR above 1.5x RGLD's 14.81%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-52.64%
Negative near-term dividend growth while RGLD invests at 43.73%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
3.32%
AR growth is negative/stable vs. RGLD's 11.69%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
-100.00%
Inventory is declining while RGLD stands at 0.00%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-1.23%
Negative asset growth while RGLD invests at 0.25%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-7.41%
We have a declining book value while RGLD shows 0.13%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-10.63%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-0.92%
We cut SG&A while RGLD invests at 20.32%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.